We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Proposed Combo Products Rule Underestimates Cost of GMPs
Proposed Combo Products Rule Underestimates Cost of GMPs
December 30, 2009
The FDA’s proposed rule on good manufacturing practices (GMPs) for combination products grossly underestimates the burden of applying certain cGMP requirements to device-drug combinations, a device company says.